Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 51.7
(-4.44%)
TWD 51.7
(-4.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.97 Billion TWD | 0.91% |
| 2022 | 1.95 Billion TWD | 943.03% |
| 2021 | 187.58 Million TWD | -0.42% |
| 2020 | 188.37 Million TWD | -77.31% |
| 2019 | 830.31 Million TWD | 58.49% |
| 2018 | 523.89 Million TWD | -8.16% |
| 2017 | 570.44 Million TWD | 83.38% |
| 2016 | 311.08 Million TWD | 26.62% |
| 2015 | 245.67 Million TWD | 188.56% |
| 2014 | 85.13 Million TWD | 2822.69% |
| 2013 | 2.91 Million TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 287.05 Million TWD | -85.5% |
| 2024 Q1 | 1.97 Billion TWD | 0.24% |
| 2023 Q1 | 1.96 Billion TWD | 0.21% |
| 2023 Q3 | 1.96 Billion TWD | 0.24% |
| 2023 Q2 | 1.96 Billion TWD | 0.23% |
| 2023 Q4 | 1.97 Billion TWD | 0.24% |
| 2023 FY | 1.97 Billion TWD | 0.91% |
| 2022 Q4 | 1.95 Billion TWD | 0.17% |
| 2022 Q3 | 1.95 Billion TWD | 0.09% |
| 2022 Q2 | 1.95 Billion TWD | 580.85% |
| 2022 FY | 1.95 Billion TWD | 943.03% |
| 2022 Q1 | 286.62 Million TWD | 52.8% |
| 2021 Q2 | 200.98 Million TWD | 6.83% |
| 2021 FY | 187.58 Million TWD | -0.42% |
| 2021 Q4 | 187.58 Million TWD | -0.28% |
| 2021 Q1 | 188.12 Million TWD | -0.13% |
| 2021 Q3 | 188.11 Million TWD | -6.41% |
| 2020 Q4 | 188.37 Million TWD | -72.0% |
| 2020 FY | 188.37 Million TWD | -77.31% |
| 2020 Q1 | 746.69 Million TWD | -10.07% |
| 2020 Q2 | 655.89 Million TWD | -12.16% |
| 2020 Q3 | 672.71 Million TWD | 2.56% |
| 2019 FY | 830.31 Million TWD | 58.49% |
| 2019 Q2 | 816.59 Million TWD | -2.64% |
| 2019 Q3 | 790.45 Million TWD | -3.2% |
| 2019 Q4 | 830.31 Million TWD | 5.04% |
| 2019 Q1 | 838.77 Million TWD | 60.1% |
| 2018 Q4 | 523.89 Million TWD | -0.9% |
| 2018 FY | 523.89 Million TWD | -8.16% |
| 2018 Q3 | 528.63 Million TWD | -2.71% |
| 2018 Q2 | 543.35 Million TWD | -2.98% |
| 2018 Q1 | 560.01 Million TWD | -1.83% |
| 2017 Q3 | 468.2 Million TWD | 0.0% |
| 2017 Q2 | 468.2 Million TWD | 0.0% |
| 2017 Q1 | - TWD | -100.0% |
| 2017 FY | 570.44 Million TWD | 83.38% |
| 2017 Q4 | 570.44 Million TWD | 21.84% |
| 2016 Q1 | 331.84 Million TWD | 35.07% |
| 2016 Q2 | 314.19 Million TWD | -5.32% |
| 2016 Q4 | 311.08 Million TWD | 0.0% |
| 2016 FY | 311.08 Million TWD | 26.62% |
| 2015 Q3 | 262.25 Million TWD | 66.62% |
| 2015 Q1 | 155.44 Million TWD | 82.58% |
| 2015 Q2 | 157.39 Million TWD | 1.26% |
| 2015 FY | 245.67 Million TWD | 188.56% |
| 2015 Q4 | 245.67 Million TWD | -6.32% |
| 2014 FY | 85.13 Million TWD | 2822.69% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | 84.6 Million TWD | 0.0% |
| 2014 Q4 | 85.13 Million TWD | 0.64% |
| 2013 FY | 2.91 Million TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -13635.325% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | -373.472% |
| Visgeneer Inc. | 158.6 Million TWD | -1144.879% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | -596.184% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -226848.621% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -14719.883% |
| NaviFUS Corp. | 32.69 Million TWD | -5939.375% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -14981.37% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -366898.699% |
| TaiRx, Inc. | 12.28 Million TWD | -15970.755% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -7180.163% |
| Lin BioScience, Inc. | 42.87 Million TWD | -4505.353% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -168512.553% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -15557.835% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -142665.944% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -3292.181% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | -390.239% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | -1034.17% |
| RBC Bioscience Corporation | 487.36 Million TWD | -305.131% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | -1640.419% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | -189.609% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -36255.238% |
| AP Biosciences Inc | 82.07 Million TWD | -2305.552% |
| EirGenix Inc. | 465.16 Million TWD | -324.461% |
| Enimmune corporation | 45.73 Million TWD | -4217.254% |
| Lukas Biomedical Inc. | 82.55 Million TWD | -2291.682% |
| GlycoNex Incorporation | 900 Thousand TWD | -219283.667% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -54868.068% |
| Level Biotechnology Inc. | 13.5 Million TWD | -14523.411% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | -1267.643% |
| TaiMed Biologics Inc. | 750.85 Million TWD | -162.961% |
| Mycenax Biotech Inc. | 726.27 Million TWD | -171.859% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -93298.912% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -45248.025% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | -516.764% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -18185.358% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | -1937.808% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -24670.455% |
| Neith Corporation | 3.54 Million TWD | -55659.757% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | -404.424% |
| VBI | - TWD | -Infinity% |
| BiOptic Inc. | 93.19 Million TWD | -2018.557% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -33376.653% |
| Sinew Pharma Inc. | 6.46 Million TWD | -30445.374% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | -906.686% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | -668.156% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 32.188% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -18923.538% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -20465.077% |
| Intech Biopharm Corporation | 1.43 Billion TWD | -37.587% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | -396.156% |
| TCI GENE Inc. | 6.79 Million TWD | -28957.439% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -23637.112% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | -635.03% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -18383.926% |
| PharmaEngine, Inc. | 14.8 Million TWD | -13232.791% |
| Savior Lifetec Corporation | 270.37 Million TWD | -630.262% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -2543.637% |
| OBI Pharma, Inc. | 501.05 Million TWD | -294.061% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | -5700.561% |
| Acepodia, Inc. | 273.81 Million TWD | -621.101% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -9551.251% |